
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway
Alexander Swoboda, Robert Soukup, Oliver Eckel, et al.
Oncogene (2020) Vol. 40, Iss. 6, pp. 1091-1105
Open Access | Times Cited: 55
Alexander Swoboda, Robert Soukup, Oliver Eckel, et al.
Oncogene (2020) Vol. 40, Iss. 6, pp. 1091-1105
Open Access | Times Cited: 55
Showing 1-25 of 55 citing articles:
Signal pathways of melanoma and targeted therapy
Weinan Guo, Huina Wang, Chunying Li
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 228
Weinan Guo, Huina Wang, Chunying Li
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 228
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Pharmacological Research (2022) Vol. 182, pp. 106311-106311
Closed Access | Times Cited: 115
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Pharmacological Research (2022) Vol. 182, pp. 106311-106311
Closed Access | Times Cited: 115
The journey from melanocytes to melanoma
Patricia P. Centeno, Valeria Pavet, Richard Marais
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 372-390
Closed Access | Times Cited: 88
Patricia P. Centeno, Valeria Pavet, Richard Marais
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 372-390
Closed Access | Times Cited: 88
Immunoediting instructs tumor metabolic reprogramming to support immune evasion
Chin‐Hsien Tsai, Yu‐Ming Chuang, Xiaoyun Li, et al.
Cell Metabolism (2023) Vol. 35, Iss. 1, pp. 118-133.e7
Open Access | Times Cited: 60
Chin‐Hsien Tsai, Yu‐Ming Chuang, Xiaoyun Li, et al.
Cell Metabolism (2023) Vol. 35, Iss. 1, pp. 118-133.e7
Open Access | Times Cited: 60
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway
Jan Pěnčík, C. Philippe, Michaela Schlederer, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Jan Pěnčík, C. Philippe, Michaela Schlederer, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Integrative functional genomic analyses identify genetic variants influencing skin pigmentation in Africans
Yuanqing Feng, Ning Xie, Fumitaka Inoue, et al.
Nature Genetics (2024) Vol. 56, Iss. 2, pp. 258-272
Open Access | Times Cited: 9
Yuanqing Feng, Ning Xie, Fumitaka Inoue, et al.
Nature Genetics (2024) Vol. 56, Iss. 2, pp. 258-272
Open Access | Times Cited: 9
Dihydrotanshinone I enhanced BRAF mutant melanoma treatment efficacy by inhibiting the STAT3/SOX2 signaling pathway
Xing Luo, Yi Duan, Jian He, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
Xing Luo, Yi Duan, Jian He, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
Duck pan‐genome reveals two transposon insertions caused bodyweight enlarging and white plumage phenotype formation during evolution
Kejun Wang, Guoying Hua, Jingyi Li, et al.
iMeta (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 21
Kejun Wang, Guoying Hua, Jingyi Li, et al.
iMeta (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 21
Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers
Lloyd A. Greene, Qing Zhou, Markus D. Siegelin, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 581-581
Open Access | Times Cited: 20
Lloyd A. Greene, Qing Zhou, Markus D. Siegelin, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 581-581
Open Access | Times Cited: 20
Identification of marine natural product Pretrichodermamide B as a STAT3 inhibitor for efficient anticancer therapy
Rui Li, Yue Zhou, Xinxin Zhang, et al.
Marine Life Science & Technology (2023) Vol. 5, Iss. 1, pp. 94-101
Open Access | Times Cited: 17
Rui Li, Yue Zhou, Xinxin Zhang, et al.
Marine Life Science & Technology (2023) Vol. 5, Iss. 1, pp. 94-101
Open Access | Times Cited: 17
Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis
Hannah M. Neuendorf, Jacinta L. Simmons, Glen M. Boyle
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
Hannah M. Neuendorf, Jacinta L. Simmons, Glen M. Boyle
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
Dormancy of cutaneous melanoma
Kathrin Singvogel, Birgit Schittek
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Kathrin Singvogel, Birgit Schittek
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Interleukin-8 in Melanoma Pathogenesis, Prognosis and Therapy—An Integrated View into Other Neoplasms and Chemokine Networks
Anca Filimon, Iulia A. Preda, Adina F. Boloca, et al.
Cells (2021) Vol. 11, Iss. 1, pp. 120-120
Open Access | Times Cited: 31
Anca Filimon, Iulia A. Preda, Adina F. Boloca, et al.
Cells (2021) Vol. 11, Iss. 1, pp. 120-120
Open Access | Times Cited: 31
Late stage melanoma is hallmarked by low NLGN4X expression leading to HIF1A accumulation
David Schörghofer, Laurenz Vock, Madalina A. Mirea, et al.
British Journal of Cancer (2024)
Open Access | Times Cited: 4
David Schörghofer, Laurenz Vock, Madalina A. Mirea, et al.
British Journal of Cancer (2024)
Open Access | Times Cited: 4
Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis
Alberto Carretero-González, Marta Hergueta‐Redondo, Sara Sánchez‐Redondo, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 18
Alberto Carretero-González, Marta Hergueta‐Redondo, Sara Sánchez‐Redondo, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 18
Melanoma metastasis: What role does melanin play? (Review)
Anoosha Saud, Sreenivasa Rao Sagineedu, Hui Suan Ng, et al.
Oncology Reports (2022) Vol. 48, Iss. 6
Open Access | Times Cited: 18
Anoosha Saud, Sreenivasa Rao Sagineedu, Hui Suan Ng, et al.
Oncology Reports (2022) Vol. 48, Iss. 6
Open Access | Times Cited: 18
Inflammasome activation in melanoma progression: the latest update concerning pathological role and therapeutic value
Nakaraj Pluetrattanabha, Thanyaporn Direksunthorn, Irfan Ahmad, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Nakaraj Pluetrattanabha, Thanyaporn Direksunthorn, Irfan Ahmad, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Isoliquiritigenin attenuates tumor progression and PD-L1 expression by inhibiting the phosphorylation of STAT3 in melanoma
Haiyan Zeng, Aoxiang Guo, Liu Zhenyang, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Haiyan Zeng, Aoxiang Guo, Liu Zhenyang, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Integrated Transcriptomic and Epigenomic Analysis Reveals Mechanisms Underlying Melanotic Spot Formation in Red Tilapia (Oreochromis spp.)
Ziyuan Qi, J. Liu, Jiale Shi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4370-4370
Open Access
Ziyuan Qi, J. Liu, Jiale Shi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4370-4370
Open Access
CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma
Jingrun Yang, Yang Xu, Kuixia Xie, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Jingrun Yang, Yang Xu, Kuixia Xie, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Malat1 regulates PMN-MDSC expansion and immunosuppression through p-STAT3 ubiquitination in sepsis
Yaodong Wang, Caiyan Zhang, Tingyan Liu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1529-1546
Open Access | Times Cited: 3
Yaodong Wang, Caiyan Zhang, Tingyan Liu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1529-1546
Open Access | Times Cited: 3
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment
Christina Sternberg, Martin Raigel, Tanja Limberger, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Christina Sternberg, Martin Raigel, Tanja Limberger, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Design, synthesis, and biological characterization of a potent STAT3 degrader for the treatment of gastric cancer
Haobin Li, Lingling Wang, Fei Cao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Haobin Li, Lingling Wang, Fei Cao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Subcapsular Sinus Macrophages Promote Melanoma Metastasis to the Sentinel Lymph Nodes via an IL1α–STAT3 Axis
Tommaso Virgilio, Joy Bordini, Luciano Cascione, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 12, pp. 1525-1541
Open Access | Times Cited: 12
Tommaso Virgilio, Joy Bordini, Luciano Cascione, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 12, pp. 1525-1541
Open Access | Times Cited: 12
Enhancing Immunogenicity in Metastatic Melanoma: Adjuvant Therapies to Promote the Anti-Tumor Immune Response
Sandra Pelka, Chandan Guha
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2245-2245
Open Access | Times Cited: 7
Sandra Pelka, Chandan Guha
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2245-2245
Open Access | Times Cited: 7